DiaSys launches SARS-CoV-2 UTAB FS for reliable monitoring of total antibodies for SARS-CoV-2

Quantitative assessment of antibodies in Covid-19 is becoming increasingly important. It provides information on the actual spread
of infection in the population and enables characterization of a vaccine-induced immune response.

Of particular interest is the determination of antibodies targeting the receptor-binding domain (RBD) in the viral spike 1 protein since these antibodies show neutralizing properties; they are able to suppress the attachment of the virus to the host cell and thus its infection. The new SARS-CoV-2 UTAB FS (UTAB = Universal Total AntiBody) launched by DiaSys, is an immunoturbidimetric test for quantitative determination of total antibodies in COVID-19. The test is characterized by high specificity and sensitivity and shows no cross-reactivity with antibodies present to other seasonal cold pathogens from the coronavirus group. The liquid stable, ready-to-use reagent with matched calibrators, controls and a sample dilution matrix may be used on almost all clinical chemistry analyzers, providing comparable results and, therefore, enables reliable monitoring of patients.

Request information

Get in touch directly with the above supplier

Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: read our privacy policy.

I’m interested in:

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.